Marshall Wace’s Juno Therapeutics, Inc. JUNO Stock Holding History

Marshall Wace’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,754	Closed	-$354K	–	696
2017 Q4	$354K	Buy	+7,754	New	+$387K	0.01%	336
2017 Q3	–	Sell	-35,687	Closed	-$1.07M	–	448
2017 Q2	$1.07M	Buy	+35,687	New	+$881K	0.05%	193
2016 Q2	–	Sell	-16,202	Closed	-$617K	–	1279
2016 Q1	$617K	Buy	+16,202	New	+$565K	0.01%	817
2015 Q1	–	Sell	-62,514	Closed	-$3.26M	–	1013
2014 Q4	$3.26M	Buy	+62,514	New	+$2.8M	0.04%	382

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Marshall Wace's JUNO Position: Q1 2018 in Review

Marshall Wace sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 7,754 shares — an estimated $354K sold.

Marshall Wace first reported a position in JUNO in Q4 2014 and held it in 4 quarters. The position peaked at $3.26M in Q4 2014. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Marshall Wace reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Marshall Wace sold 7,754 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $354K.
Marshall Wace first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 4 quarters.
Marshall Wace's Juno Therapeutics, Inc. position peaked at $3.26M in Q4 2014.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Marshall Wace's 13F filing for Q1 2018, filed 15 May 2018.